Clinical Trials

A clinical trial is a research study that tries to find better ways to prevent, screen for, diagnose, or treat a disease like bladder cancer.  They are an essential part of cancer research.  Trials may provide possible treatment alternatives to patients who have not had success with standard and approved therapies.

You can search for a clinical trial below by bladder cancer disease state, state of residence and you can also look for trials nearest to you.

About Clinical Trials

To help find trials near you, you need to allow BCAN to access your location
Ok

Title State Sponsoring Organization
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors Multi-State National Cancer Institute (NCI)
Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer Multi-State National Cancer Institute (NCI)
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer Multi-State National Cancer Institute (NCI)
A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid Tumors Multi-State Pfizer
Study of NGM120 in Subjects With Advanced Solid Tumors and Pancreatic Cancer Using Combination Therapy Multi-State NGM Biopharmaceuticals, Inc
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study Multi-State Steba Biotech S.A.
A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma Multi-State Novartis Pharmaceuticals
A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer Multi-State Memorial Sloan Kettering Cancer Center
Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies Multi-State Pfizer

This page is proudly sponsored by Astellas/SeaGen, AstraZeneca, Bristol Myers Squibb, CG Oncology, Janssen, Pfizer,  Pharmacyclics and UroGen Pharma.

Learn more about the different phases clinical trials here.